Programs, populations, and payments verified via SAMHSA.
- Level of care
- Inpatient · MAT · Dual Dx · Telehealth
- Service settings
- Residential/24-hour residential, Long-term residential
- Therapy approaches
- Anger management, Brief intervention, Cognitive behavioral therapy, Contingency management/motivational incentives, Relapse prevention, Substance use disorder counseling, Trauma-related counseling, Telemedicine/telehealth therapy
- Age groups
- Children/Adolescents, Young Adults, Adults
- Special populations
- Adolescents, Pregnant/postpartum women, Criminal justice (other than DUI/DWI)/Forensic clients, Clients with co-occurring mental and substance use disorders, Clients with co-occurring pain and substance use disorders, Clients with HIV or AIDS, Clients who have experienced sexual abuse, Clients who have experienced intimate partner violence, domestic violence, Clients who have experienced trauma
- Medications used
- Acamprosate (Campral®), Buprenorphine with naloxone, Buprenorphine without naloxone, Buprenorphine (extended-release, injectable), Naltrexone (oral), Naltrexone (extended-release, injectable), Medications for HIV treatment, Medications for Hepatitis C treatment, Lofexidine, Clonidine + 4 more
- Recovery supports
- Self-help groups, Housing services, Assistance with obtaining social services, Mentoring/peer support, Employment counseling or training
- Facility operation
- Indian Health Services, Federal Government